Please login to the form below

Not currently logged in
Email:
Password:

pSivida Strengthens board with new non-executive director

Australia-headquartered drug delivery company pSivida has hired Dr Katherine Woodthorpe as a non-executive director.

Australia-headquartered drug delivery company pSivida has hired Dr Katherine Woodthorpe as a non-executive director.

Dr Woodthorpe is CEO of AVCAL (Australian Private Equity and Venture Capital Association) and has an extensive background as a management adviser and director, including working with Australian technology companies seeking venture funding to being a board member of listed companies. She has also consulted with government groups on innovation and commercialisation.

Woodthorpe is also chair of the Antarctic Climate and Ecosystems Cooperative Research Centre, director of Insearch and a council member of the University of Technology Sydney.

pSivida's managing director, Dr Paul Ashton, said: "We are very fortunate to have Katherine join the board. Katherine brings a unique and powerful blend of scientific and business skills that we believe will greatly assist pSivida."

Prior to AVCAL, Woodthorpe worked as a professional non-executive director and management adviser. Her areas of expertise included developing strategies for rapid growth and commercialization of technology products and services.

Stephen Lake, who joined pSivida's board in July 2004 decided to stand down as a director to focus on the launch of a new technology fund in the UK.

6th August 2007

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
infill healthcare communication

infill is a dynamic and innovative, international healthcare agency with >25 years' experience in delivering healthcare communication, medical education and...

Latest intelligence

International Childhood Cancer Day 2019
The number of new cases per year is shocking but the journey and the outlooks have vastly improved. We've pulled together an infographic to show just what we mean with...
Immuno-oncology in 2019: the rapid evolution continues
Immunotherapy is pharma’s biggest growth driver – how will it develop in 2019?...
Mixing up Focus Groups
A nice spread of homogeneous participants in a focus groups are often a go to for reliable research outcomes but there's much to be said for mixing it up and...

Infographics